Exhibit 99.1

JOINT FILING UNDERTAKING

The undersigned, who, together, may be deemed to form a group under section 13(d)(3) of the Securities Exchange Act, being authorized thereunto, hereby agree that the Statement on Schedule 13G, dated December 9, 2024, with respect to the ordinary shares, no par value, of NeuroSense Therapeutics, Ltd., and any amendments thereto, executed by each and any of the undersigned shall be filed by each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, and as an exhibit to the Schedule 13G to evidence the agreement of the below-named parties to file this Schedule 13G, and any amendments hereto, jointly on behalf of each of such parties.

Dated: December 9, 2024
	RIMON GOLD ASSETS LTD.
	By:	/s/ Abir Raveh
		Name:	Abir Raveh
		Title:	Director
	ABIR RAVEH
	By:	/s/ Abir Raveh
	GOLDFINGER TRUST
	By:	/s/ Abir Raveh
		Name:	Abir Raveh
		Title:	Trustee